E-mini S&amp;P500 +2.9% after optimistic headlines on Univ of Chicago Phase3 trial of Gilead drug for #Covid_19. The #ES_F vaulted its 50 day MA and is ~2.2% of eyed 61.8% Fib. Old adage is bear mkts don't get overbought so S/T momentum near key area. 73% of #SP500 still &lt; 50 day MA. https://t.co/Yde0ZTYrtu